Search by topic:
18 October 2021 by Marcus Gordon
An experimental drug, molnupiravir, for severe Covid cuts the risk of hospitalisation or death by about half, according to initial clinical trial results.
This potentially adds a new tool to our toolkit in our fighting against covid19.
To find out more about this new pill and the study, click the link below: